바이오인프라

199730KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

1,640KRWMarket close of 10/28 (Wed)

Up +2.44%+39KRWMarket close of 10/28 (Wed)

Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/29 (Thu)1,362KRWDown -16.95%

Preliminary · replaced once official KRX data for the same date is published

Open
1,690
High
1,690
Low
1,562
Day range
Day range low 1,562 high 1,690, open 1,690, close 1,640, previous close 1,601
Volume
10×10K shares
165.67 million KRW 0.10× the 20-session average

Market close of 10/28 (Wed)

Where it sits in the 1-year range

1-year close range 602 to 5,320 won, 22% up from the low

22% of the way up from the lowest close in 1 year (252 sessions) · -69.2% from the high

Loading

Free · no sign-inSource from 2021-05-17

Data dateMost recent closing data10/28 (Wed)
Market close data of 2026-10-28

Points to check

  • Earningsnot verifiedOutside financial data coverage, so not verified
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 2 are within the usual range

  • Daily move+2.44%usual range
  • Trading value0.1×usual range
See the full check report

Same sector · 바이오 R&D

Up +1.90%

· 40 of 64 stocks up, preferred shares excluded · trading value 209.6B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -12.0%Up +2.06%52.9B KRW
디앤디파마텍Close over the last 20 sessions +2.3%Up +5.15%28.1B KRW
올릭스Close over the last 20 sessions -5.4%Up +7.40%22.0B KRW
리가켐바이오Close over the last 20 sessions -16.7%Up +3.60%13.4B KRW
프로티나Close over the last 20 sessions -3.9%Up +5.21%10.3B KRW

Schedule

  • Next data 10/30 (Fri) after 08:50

Related news

All news
Loading

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 83% of trading value, about 93% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.